Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000-2016: a Danish population-based study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Addressing the room for improvement in management of acute promyelocytic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Lasse Hjort Jakobsen
  • Anne Stidsholt Roug
  • Andreas Kiesbye Øvlisen
  • Claus Werenberg Marcher
  • Hans Beier Ommen
  • Kim Theilgaard-Mönch
  • Peter Møller
  • Claudia Schöllkopf
  • Daniel Kristensen
  • Therese Maria Henriette Naur
  • Martin Bøgsted
  • Tarec Christoffer El-Galaly
  • Marianne Tang Severinsen
View graph of relations

In the present study, we quantify the progress in overall survival (OS) during the period 2000-2016 among Danish patients with acute myeloid leukaemia (AML). This population-based study, including 3820 adult patients with AML, demonstrates a significantly improved OS over time with the 2-year age-standardised OS increasing from 22% in 2002 to 31% in 2016. The improvement in OS was exclusively seen in patients with AML aged ≥50 years, with absolute improvements in 2-year OS from 2002 to 2016 of ≥10% among patients aged 50-75 years and a small absolute increase in those aged >75 years.

Original languageEnglish
JournalBritish Journal of Haematology
Volume193
Issue number3
Pages (from-to)482-487
Number of pages6
ISSN0007-1048
DOIs
Publication statusPublished - May 2021

    Research areas

  • acute myeloid leukaemia, temporal survival, real&#8208, world patients, real-world patients

ID: 61529937